Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Melanoma

Clinical trial condition

Malignant Melanoma

Explore clinical trials studying Malignant Melanoma. Study availability and eligibility vary by location and protocol.

168 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Malignant Melanoma trial results

Completed

Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

NCT00327600

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Investigational Site 009 Los Angeles, California, United States

Investigational Site 002 Santa Monica, California, United States

University of CO Anschutz Cancer Pavilion Aurora, Colorado, United States

US Oncology Orlando, Cancer Centers of FL Ocoee, Florida, United States

View Trial Details

Completed

International Melanoma Algorithm Training Study - IMATS

NCT00966173

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Sahlgrenska University Hospital, Dpt. of Dermatology Gothenburg, Sweden

View Trial Details

Completed

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

NCT00729950

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Piedmont Oncology Specialists Charlotte, North Carolina, United States

Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

NCT00034554

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: ImClone Investigational Site New York, United States

View Trial Details

Completed

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

NCT00911443

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: CHU de Grenoble Hopital Albert Michallon Service de Dermatologie La Tronche, France

CHU de Limoges Hopital Dupuytren Service de Dermatologie Limoges, France

Hopital Saint-Eloi Service de Dermatologie Montpellier, France

Centre Eugene Marquis Departement d'Oncologie Medicale Rennes, France

View all 64 locations

View Trial Details

Completed

Sentinel Node With Ultrasound Contrast in Melanoma

NCT00370136

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Copenhagen univercity hospital, Department of Radiology, section of ultrasound Copenhagen, Denmark

View Trial Details

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

NCT00306566

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Centre Pluridisciplinaire d'Oncologie & LICR, CHUV Lausanne, Vaude, Switzerland

View Trial Details

Completed

Clinical Study of Previously Untreated Patients With Malignant Melanoma

NCT00232726

Conditions: Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

The Norwegian Radium Hospital Oslo, Norway

University Hospital Lund, Sweden

View Trial Details

Completed

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

NCT00204607

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Department of Dermatology, University of Tübingen Tübingen, Germany

View Trial Details

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

NCT00306553

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Dept. of Dermatology, USZ Zurich, Canton of Zurich, Switzerland

Dept. of Oncology, USZ Zurich, Canton of Zurich, Switzerland

View Trial Details